We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Sarah
Gelcich
s.gelcich@leeds.ac.uk
Prof
Galina
Velikova
g.velikova@leeds.ac.uk
Malignant neoplasm of breastMalignant neoplasms of digestive organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This project aims to enhance the support for patients with breast and bowel cancer after treatment. Current follow-up care includes either self-management with patient-initiated contacts (breast cancer) or scheduled hospital visits for scans/tests for recurrence (bowel cancer). Building on extensive experience with online patient self-reporting of symptoms during treatment, we plan to develop, implement and evaluate satisfaction with an improved electronic system to engage breast and bowel cancer survivors to self-report symptoms/problems online from home and get immediate tailored advice for self-management or hospital contact. The reports are displayed real-time in the hospital records alongside scans/tests to inform clinical management.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Education or Self-Management;Psychological & Behavioural;Management of Care;Active Monitoring;
You can take part if:
You may not be able to take part if:
•Patients under the age of 16 •Patients exhibiting overt psychopathology/cognitive dysfunction •Patients taking part in other clinical trials involving the completion of extensive patient reported outcome or quality of life measures
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Leeds and funded by YORKSHIRE CANCER RESEARCH .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 46851
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
